| Style | Citing Format |
|---|---|
| MLA | Toscano S, et al.. "First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis." Neurotherapeutics, vol. 22, no. 2, 2025, pp. -. |
| APA | Toscano S, Spelman T, Ozakbas S, Alroughani R, Chisari CG, Lo Fermo S, Prat A, Girard M, Duquette P, Izquierdo G, Eichau S, Grammond P, Boz C, Kalincik T, Blanco Y, Buzzard K, Skibina O, Sa MJ, Van Der Walt A, ... Patti F (2025). First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis. Neurotherapeutics, 22(2), -. |
| Chicago | Toscano S, Spelman T, Ozakbas S, Alroughani R, Chisari CG, Lo Fermo S, Prat A, et al.. "First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis." Neurotherapeutics 22, no. 2 (2025): -. |
| Harvard | Toscano S et al. (2025) 'First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis', Neurotherapeutics, 22(2), pp. -. |
| Vancouver | Toscano S, Spelman T, Ozakbas S, Alroughani R, Chisari CG, Lo Fermo S, et al.. First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis. Neurotherapeutics. 2025;22(2):-. |
| BibTex | @article{ author = {Toscano S and Spelman T and Ozakbas S and Alroughani R and Chisari CG and Lo Fermo S and Prat A and Girard M and Duquette P and Izquierdo G and Eichau S and Grammond P and Boz C and Kalincik T and Blanco Y and Buzzard K and Skibina O and Sa MJ and Van Der Walt A and Butzkueven H and Terzi M and Gerlach O and Grandmaison F and Foschi M and Surcinelli A and Barnett M and Lugaresi A and Onofrj M and Yamout B and Khoury SJ and Prevost J and Lechnerscott J and Maimone D and Amato MP and Spitaleri D and Van Pesch V and Macdonell R and Cartechini E and De Gans K and Slee M and Castillotrivino T and Soysal A and Sanchezmenoyo JL and Laureys G and Van Hijfte L and Mccombe P and Altintas A and Weinstockguttman B and Agueramorales E and Etemadifar M and Ramotello C and John N and Turkoglu R and Hodgkinson S and Besora S and Van Wijmeersch B and Fernandezbolanos R and Patti F}, title = {First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis}, journal = {Neurotherapeutics}, volume = {22}, number = {2}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - Toscano S AU - Spelman T AU - Ozakbas S AU - Alroughani R AU - Chisari CG AU - Lo Fermo S AU - Prat A AU - Girard M AU - Duquette P AU - Izquierdo G AU - Eichau S AU - Grammond P AU - Boz C AU - Kalincik T AU - Blanco Y AU - Buzzard K AU - Skibina O AU - Sa MJ AU - Van Der Walt A AU - Butzkueven H AU - Terzi M AU - Gerlach O AU - Grandmaison F AU - Foschi M AU - Surcinelli A AU - Barnett M AU - Lugaresi A AU - Onofrj M AU - Yamout B AU - Khoury SJ AU - Prevost J AU - Lechnerscott J AU - Maimone D AU - Amato MP AU - Spitaleri D AU - Van Pesch V AU - Macdonell R AU - Cartechini E AU - De Gans K AU - Slee M AU - Castillotrivino T AU - Soysal A AU - Sanchezmenoyo JL AU - Laureys G AU - Van Hijfte L AU - Mccombe P AU - Altintas A AU - Weinstockguttman B AU - Agueramorales E AU - Etemadifar M AU - Ramotello C AU - John N AU - Turkoglu R AU - Hodgkinson S AU - Besora S AU - Van Wijmeersch B AU - Fernandezbolanos R AU - Patti F TI - First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis JO - Neurotherapeutics VL - 22 IS - 2 SP - EP - PY - 2025 ER - |